Breaking News Instant updates and real-time market news.

USO

United States Oil Fund

$10.84

0.34 (3.24%)

, XOM

Exxon Mobil

$72.06

0.02 (0.03%)

11:40
01/09/19
01/09
11:40
01/09/19
11:40

Saudi Energy Minister says Aramco IPO expected in 2021, WSJ reports

USO

United States Oil Fund

$10.84

0.34 (3.24%)

XOM

Exxon Mobil

$72.06

0.02 (0.03%)

CVX

Chevron

$113.21

1.48 (1.32%)

RDS.A

Royal Dutch Shell

$60.65

0.4 (0.66%)

TOT

Total

$55.20

1 (1.85%)

COP

ConocoPhillips

$65.53

1.23 (1.91%)

BP

BP

$40.25

0.22 (0.55%)

  • 09

    Jan

  • 01

    Feb

  • 10

    Feb

  • 28

    May

USO United States Oil Fund
$10.84

0.34 (3.24%)

XOM Exxon Mobil
$72.06

0.02 (0.03%)

11/26/18
WOLF
11/26/18
UPGRADE
WOLF
Outperform
Exxon Mobil upgraded to Outperform from Peer Perform at Wolfe Research
11/20/18
11/20/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Exxon Mobil (XOM) downgraded to Underperform from Market Perform at Raymond James with analyst Pavel Molchanov saying Exxon Mobil is "one of the least appealing ways to play" the firm's bullish oil call, particularly following the recent oil price selloff. 2. Skyworks (SWKS) downgraded to Underperform from Neutral at BofA/Merrill with analyst Vivek Arya citing limited content gains in 2019 iPhones. 3. Micron (MU) downgraded two notches to Underperform from Outperform at Baird with analyst Tristan Gerra saying he now models eight consecutive quarters of gross margin and EPS contraction given the continued deterioration in both DRAM and NAND memory pricing. 4. Nvidia (NVDA) downgraded to Underperform from Neutral at Exane BNP Paribas. 5. Western Digital (WDC) downgraded to Neutral from Positive at Susquehanna with analyst Mehdi Hosseini saying he has lost confidence in the company's ability to benefit from SSD substitution of HDDs. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/20/18
11/20/18
DOWNGRADE

Underperform
Exxon Mobil downgraded to Underperform at Raymond James
As previously reported, Raymond James downgraded Exxon Mobil to Underperform from Market Perform. Analyst Pavel Molchanov said Exxon Mobil is "one of the least appealing ways to play" the firm's bullish oil call, particularly following the recent oil price selloff. Molchanov believes Exxon shares will be a source of funds and notes free cash flow yield is below peer group median and is the only supermajor that is not returning capital to shareholders through buybacks.
11/20/18
RAJA
11/20/18
DOWNGRADE
RAJA
Underperform
Exxon Mobil downgraded to Underperform from Market Perform at Raymond James
CVX Chevron
$113.21

1.48 (1.32%)

11/05/18
11/05/18
UPGRADE
Target $138

Outperform
Chevron upgraded to Outperform on continued execution at Credit Suisse
As previously reported, Credit Suisse analyst William Featherston upgraded Chevron to Outperform from Neutral, with a $138 price target, citing continued execution, free cash flow visibility and compelling valuation. The analyst believes the company continues to execute on its already superior growth outlook, which should translate into better than expected capital efficiencies into 2019 and sets up for continued robust free cash flow. He sees upside to 2019-2020 volume forecasts supported by strong Permian growth, driving an estimated about $10B-$11B per annum of surplus free cash flow generation, which should enable Chevron to sustain competitive dividend growth and expand the scope of its current share buyback program.
11/05/18
FBCO
11/05/18
UPGRADE
FBCO
Outperform
Chevron upgraded to Outperform from Neutral at Credit Suisse
10/22/18
SIMM
10/22/18
INITIATION
Target $139
SIMM
Overweight
Chevron assumed with an Overweight at Simmons
Simmons analyst Blake Fernandez assumed Chevron with an Overweight rating and a price target of $139 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez adds that Chevron is his Top Idea given that it had the worst year-to-date equity performance in the peer group and expects the stock to "play catch-up". The analyst further points to the company's "ample Permian takeaway capacity" as alleviation of "industry bottlenecks next year could prompt fund rotation back into equities with leverage" to the region.
10/03/18
REDB
10/03/18
DOWNGRADE
REDB
Neutral
Chevron downgraded to Neutral from Buy at Redburn
Redburn analyst Rob West downgraded Chevron to Neutral from Buy with a $115 fair value, down from $130 saying it benefits less from tightness in gas and increasing late cycle risks.
RDS.A Royal Dutch Shell
$60.65

0.4 (0.66%)

12/18/18
12/18/18
INITIATION
Target $76

Outperform
Wells Fargo starts Royal Dutch Shell at Outperform with $76 price target
As previously reported, Wells Fargo analyst Roger Read started Royal Dutch Shell with an Outperform rating and $76 price target, citing its attractive valuation, "relatively modest" reinvestment ratio and leading cash returns. He projects Shell's ROACE will essentially double to roughly 14% by 2020 versus 2017 levels based on a combination of higher production, cost-cutting, high grading of the portfolio and some degree of commodity price recovery, Read tells investors.
12/18/18
WELS
12/18/18
INITIATION
Target $76
WELS
Outperform
Royal Dutch Shell initiated with an Outperform at Wells Fargo
Wells Fargo analyst Roger Read started Royal Dutch Shell with an Outperform rating and $76 price target.
12/10/18
DBAB
12/10/18
DOWNGRADE
DBAB
Hold
Royal Dutch Shell downgraded to Hold from Buy at Deutsche Bank
Deutsche Bank analyst Lucas Herrmann downgraded Royal Dutch Shell to Hold and lowered his price target for the shares tp GBP 2,650 from GBP 2,800. The analyst believes that the less certain oil price "backcloth" will bring questions about the sustainability of both the company's buyback and 2020 CFFO guidance.
10/22/18
SIMM
10/22/18
INITIATION
Target $72
SIMM
Neutral
Royal Dutch Shell assumed with a Neutral at Simmons
Simmons analyst Blake Fernandez assumed Royal Dutch Shell with a Neutral rating and a price target of $72 as part of his broader research note on Integrated Oils, suggesting that the industry stands to benefit from the current stage of the energy cycle. Fernandez notes that the company enjoyed stronger than expected earnings last year, but its past couple of quarters have been underwhelming because of "multiple transitory culprits driving results including tax, derivatives, etc." The analyst prefers to wait for a reversal of this trend before becoming more constructive on the stock.
TOT Total
$55.20

1 (1.85%)

11/28/18
JPMS
11/28/18
UPGRADE
JPMS
Neutral
Total upgraded to Neutral from Underweight at JPMorgan
JPMorgan analyst Christyan Malek upgraded Total SA to Neutral from Underweight but lowered his price target to EUR49 from EUR54.
12/10/18
DBAB
12/10/18
UPGRADE
DBAB
Buy
Total upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Lucas Herrmann upgraded Total to Buy while lowering his price target for the shares to EUR 54 from EUR 56. The analyst sees "robust cash flow growth" in 2019 for Total.
12/11/18
BOFA
12/11/18
UPGRADE
BOFA
Buy
Total upgraded to Buy from Neutral at BofA/Merrill
12/11/18
12/11/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. AT&T (T) upgraded to Buy from Neutral at Citi with analyst Michael Rollins saying he expects AT&T to further benefit from the "measured" promotional environment in wireless, while improving its competitive position from FirstNet and the marketing of its network enhancements, branded 5G Evolution. 2. Sanofi (SNY) upgraded to Buy from Hold at Jefferies with analyst Peter Welford saying he believes European large-cap pharmaceuticals are entering a period of sustained earnings momentum which should justify valuations above the historic average for the sector. 3. Total (TOT) upgraded to Buy from Neutral at BofA/Merrill. 4. Zynga (ZNGA) upgraded to Outperform from Neutral at Macquarie. 5. Allstate (ALL) upgraded to Hold from Sell at Edward Jones. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
COP ConocoPhillips
$65.53

1.23 (1.91%)

10/29/18
10/29/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Ford (F) upgraded to Buy from Neutral at Goldman Sachs with analyst David Tamberrino saying he views the stock as a "product and self-help story" along with an "attractive" dividend yield. 2. Helmerich & Payne (HP) upgraded to Market Perform from Underperform at BMO Capital. 3. STMicroelectronics (STM) upgraded to Neutral from Sell at UBS. 4. AB InBev (BUD) upgraded to Outperform from Sector Perform at RBC Capital with analyst James Edwardes Jones saying while the company's Q3 results were "disappointing," he believes that shares were also oversold given that the company's "sales growth looks OK relative to the rest of the consumer staples sector." 5. ConocoPhillips (COP) upgraded to Buy from Neutral at BofA/Merrill with analyst Doug Leggate saying ConocoPhillips' has a favorably leveraged oil portfolio mix which is overlooked by the market and benefits from the 2014 change in the Alaska tax regime. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
12/10/18
WOLF
12/10/18
UPGRADE
WOLF
Outperform
ConocoPhillips upgraded to Outperform from Peer Perform at Wolfe Research
12/14/18
TUDR
12/14/18
UPGRADE
TUDR
Buy
ConocoPhillips upgraded to Buy from Hold at Tudor Pickering
01/04/19
BOFA
01/04/19
DOWNGRADE
Target $72
BOFA
Neutral
ConocoPhillips downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analyst Doug Leggate downgraded ConocoPhillips to Neutral from Buy and lowered its price target to $72 from $82 saying risk/reward is balanced between downside to strip prices and the firm's Brent base case of $65/bbl. Leggate acknowledges a recovery in oil prices could lead to material upside, but views volatility as the biggest challenge as too many stocks are competing for shrinking investor dollars.
BP BP
$40.25

0.22 (0.55%)

12/21/18
EVER
12/21/18
NO CHANGE
Target $42
EVER
Outperform
Golar LNG Tortue project worth $10 per share to equity, says Evercore ISI
After Kosmos Energy (KOS) and BP (BP), the equity owners in the Greater Tortue Ahmeyim project offshore Senegal and Mauritania, announced Final Investment Decision on Phase 1, which will utilize one of Golar LNG's (GLNG) FLNG vessels, Evercore ISI analyst Jonathan Chappell said he continues to estimate a nearly $10/share value to Golar LNG equity based on the expected output, start-up time, and financing. Stating that Tortue means "an awful lot" for Golar LNG, he reiterated his Outperform rating on the stock and trimmed his target to $42 from $43.
12/18/18
12/18/18
INITIATION
Target $41

Market Perform
Wells Fargo starts BP at Market Perform with $41 price target
As previously reported, Wells Fargo analyst Roger Read started BP with a Market Perform rating and $41 price target, citing his expectation that BP's total cash shareholder returns will trail its peer group through 2021. Despite an attractive valuation and production growth potential, BP's higher balance sheet leverage is a headwind to outperforming the market, Read tells investors.
12/18/18
WELS
12/18/18
INITIATION
Target $41
WELS
Market Perform
BP initiated with a Market Perform at Wells Fargo
Wells Fargo analyst Roger Read started BP with a Market Perform rating and $41 price target.
11/20/18
11/20/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. LyondellBasell (LYB) upgraded to Outperform from Sector Perform at RBC Capital with analyst Arun Viswanathan saying the shares look attractive when investors "look through oil and market volatility," anticipating the company to post "robust" EBITDA growth in 2019 and 2020. 2. BP (BP) upgraded to Outperform from Market Perform at Raymond James with analyst Jean-Pierre Dmirdjian saying poor year-to-date share performance has created an attractive entry point. He also said shares screen well on free cash flow, oil leverage, and production growth. 3. CME Group (CME) upgraded to Buy from Hold at Berenberg with analyst Chris Turner saying he expects "unsettled markets" in 2019 to provide a supportive backdrop for volumes in CME's core interest rate and currency products. 4. American Vanguard (AVD) upgraded to Buy from Hold at Loop Capital with analyst Chris Kapsch saying despite "much negativity" surrounding the broader agriculture end market amid the ongoing Trump/China trade war, American Vanguard is "navigating and executing admirably." 5. EQT Corporation (EQT) upgraded to Buy from Neutral at Goldman Sachs with analyst Brian Singer saying he believes the company's production guidance calling for 5% asset sale-adjusted growth in 2019 is conservative. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

ETFC

E-Trade

$47.45

0.88 (1.89%)

17:33
02/17/19
02/17
17:33
02/17/19
17:33
Conference/Events
E-Trade to hold Education Day »

Education Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

PFE

Pfizer

$42.41

0.45 (1.07%)

12:56
02/17/19
02/17
12:56
02/17/19
12:56
Hot Stocks
Pfizer, EMD Serono announce publication of Phase 3 data for BAVENCIO plus INLYTA »

Merck KGaA, which…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 18

    May

MRK

Merck

$79.84

0.9 (1.14%)

, PFE

Pfizer

$42.41

0.45 (1.07%)

12:48
02/17/19
02/17
12:48
02/17/19
12:48
Hot Stocks
Merck presents results from Phase 3 KEYNOTE-426 study »

Merck (MRK) announced…

MRK

Merck

$79.84

0.9 (1.14%)

PFE

Pfizer

$42.41

0.45 (1.07%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 11

    Apr

  • 18

    May

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

12:42
02/17/19
02/17
12:42
02/17/19
12:42
Hot Stocks
Aveo Pharmaceuticals presents TIVO-3 trial topline results »

Aveo Oncology announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ARDM

Aradigm

$0.00

(0.00%)

12:34
02/17/19
02/17
12:34
02/17/19
12:34
Hot Stocks
Aradigm announces plans for reorganization under Chapter 11 »

Aradigm has filed for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

, XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

13:26
02/16/19
02/16
13:26
02/16/19
13:26
Periodicals
Amazon a risk for almost every stock/sector, Barron's says »

Amazon (AMZN) is eating…

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

KR

Kroger

$29.50

0.54 (1.86%)

FAST

Fastenal

$62.97

0.61 (0.98%)

GWW

Grainger

$316.63

4.9 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

YETI

Yeti

$22.85

0.97 (4.43%)

13:20
02/16/19
02/16
13:20
02/16/19
13:20
Periodicals
Yeti stock has 60% upside, Barron's says »

Yeti Holdings stock…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

L

Loews

$46.67

0.785 (1.71%)

13:14
02/16/19
02/16
13:14
02/16/19
13:14
Periodicals
Investors can love Loews, Barron's says »

Loews is a $15B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

  • 28

    May

EQIX

Equinix

$421.53

1.16 (0.28%)

, COR

CoreSite Realty

$102.69

0.625 (0.61%)

13:10
02/16/19
02/16
13:10
02/16/19
13:10
Periodicals
Equinix, CoreSite Realty among stocks to play data-center boom, Barron's says »

Data-center stocks may…

EQIX

Equinix

$421.53

1.16 (0.28%)

COR

CoreSite Realty

$102.69

0.625 (0.61%)

IRM

Iron Mountain

$35.13

-0.14 (-0.40%)

INXN

Interxion

$64.65

0.81 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 26

    Mar

  • 26

    Mar

NOK

Nokia

$6.31

0.015 (0.24%)

, ERIC

Ericsson

$9.36

0.015 (0.16%)

13:07
02/16/19
02/16
13:07
02/16/19
13:07
Periodicals
A U.S. ban of Huawei may benefit Ericsson, Samsung, Barron's says »

The next salvo in the…

NOK

Nokia

$6.31

0.015 (0.24%)

ERIC

Ericsson

$9.36

0.015 (0.16%)

SSNLF

Samsung

$0.00

(0.00%)

CSCO

Cisco

$49.45

1.05 (2.17%)

JNPR

Juniper

$27.12

0.16 (0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 26

    Feb

  • 27

    Feb

  • 28

    Feb

COP

ConocoPhillips

$70.13

1.04 (1.51%)

, MUR

Murphy Oil

$29.23

0.59 (2.06%)

13:00
02/16/19
02/16
13:00
02/16/19
13:00
Periodicals
Dividend investors should look to oil stocks for big yields, Barron's says »

Energy stocks aren't…

COP

ConocoPhillips

$70.13

1.04 (1.51%)

MUR

Murphy Oil

$29.23

0.59 (2.06%)

CVX

Chevron

$119.30

1.19 (1.01%)

VLO

Valero

$84.34

0.75 (0.90%)

XOM

Exxon Mobil

$77.74

1.47 (1.93%)

MRO

Marathon Oil

$17.07

0.15 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

  • 07

    Mar

  • 18

    Mar

  • 22

    May

  • 28

    May

AMZN

Amazon.com

$1,608.88

-13.47 (-0.83%)

12:45
02/16/19
02/16
12:45
02/16/19
12:45
Periodicals
Protestors against NY's Amazon HQ2 got math wrong, Barron's says »

On Thursday, Amazon…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 20

    Feb

  • 20

    Feb

  • 03

    Mar

  • 18

    Mar

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

, NDAQ

Nasdaq

$87.74

0.56 (0.64%)

12:28
02/16/19
02/16
12:28
02/16/19
12:28
Periodicals
Investors interested in U.S. cannabis companies face challenges, Barron's says »

Investors interested in…

ICE

IntercontinentalExchange

$75.49

-0.46 (-0.61%)

NDAQ

Nasdaq

$87.74

0.56 (0.64%)

CGC

Canopy Growth

$47.54

1.49 (3.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 28

    May

  • 15

    Feb

AMD

AMD

$23.68

0.55 (2.38%)

, INTC

Intel

$51.64

0.85 (1.67%)

08:43
02/16/19
02/16
08:43
02/16/19
08:43
On The Fly
Week in review: How Trump's policies moved stocks »

Catch up on the top…

AMD

AMD

$23.68

0.55 (2.38%)

INTC

Intel

$51.64

0.85 (1.67%)

MRVL

Marvell

$18.82

-0.37 (-1.93%)

MCHP

Microchip

$91.10

0.49 (0.54%)

MU

Micron

$41.99

-0.23 (-0.54%)

NVDA

Nvidia

$157.22

2.69 (1.74%)

QCOM

Qualcomm

$51.97

0.42 (0.81%)

TXN

Texas Instruments

$107.55

0.57 (0.53%)

TWTR

Twitter

$31.23

0.28 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 07

    Mar

  • 07

    Mar

  • 25

    Mar

  • 26

    Mar

  • 28

    May

  • 04

    Jun

  • 05

    Jun

AMGN

Amgen

$188.31

1.6 (0.86%)

, ALPMY

Astellas Pharma

$0.00

(0.00%)

04:55
02/16/19
02/16
04:55
02/16/19
04:55
Conference/Events
American Society of Clinical Oncology to hold a symposium »

2019 ASCO Genitourinary…

AMGN

Amgen

$188.31

1.6 (0.86%)

ALPMY

Astellas Pharma

$0.00

(0.00%)

AZN

AstraZeneca

$40.92

0.93 (2.33%)

BAYRY

Bayer

$0.00

(0.00%)

BMY

Bristol-Myers

$51.64

0.81 (1.59%)

CALA

Calithera Biosciences

$5.35

0.14 (2.69%)

CLVS

Clovis

$25.44

(0.00%)

DNA

Bought by RHHBY

$0.00

(0.00%)

ESALY

Eisai

$0.00

(0.00%)

EXEL

Exelixis

$22.26

-0.05 (-0.22%)

IMMU

Immunomedics

$14.23

0.225 (1.61%)

INO

Inovio

$3.70

0.01 (0.27%)

MRK

Merck

$79.84

0.9 (1.14%)

MYOV

Myovant Sciences

$21.48

0.1 (0.47%)

MYGN

Myriad Genetics

$31.41

0.53 (1.72%)

NH

NantHealth

$0.60

(0.00%)

NVS

Novartis

$89.89

0.865 (0.97%)

PFE

Pfizer

$42.41

0.45 (1.07%)

PGNX

Progenics

$4.87

0.13 (2.74%)

SGEN

Seattle Genetics

$71.48

2.92 (4.26%)

SNY

Sanofi

$42.51

0.94 (2.26%)

TYME

Tyme Technologies

$3.19

0.055 (1.76%)

AVEO

Aveo Pharmaceuticals

$0.62

0.0092 (1.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 20

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 11

    Mar

  • 22

    Mar

  • 11

    Apr

  • 28

    Apr

  • 18

    May

  • 20

    May

WES

Western Gas Partners

$49.52

0.38 (0.77%)

, WGP

Western Gas Equity

$32.38

0.2 (0.62%)

19:30
02/15/19
02/15
19:30
02/15/19
19:30
Recommendations
Western Gas Partners, Western Gas Equity analyst commentary at MUFG »

MUFG raises price targets…

WES

Western Gas Partners

$49.52

0.38 (0.77%)

WGP

Western Gas Equity

$32.38

0.2 (0.62%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

  • 15

    Feb

  • 04

    Mar

PXD

Pioneer Natural

$145.33

2.27 (1.59%)

19:19
02/15/19
02/15
19:19
02/15/19
19:19
Recommendations
Pioneer Natural analyst commentary at MUFG »

Pioneer Natural price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

ZTS

Zoetis

$95.38

2.16 (2.32%)

18:42
02/15/19
02/15
18:42
02/15/19
18:42
Hot Stocks
Zoetis CEO says: 'Diagnostics are more important in animals than humans' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$136.40

2.13 (1.59%)

18:22
02/15/19
02/15
18:22
02/15/19
18:22
Hot Stocks
Johnson & Johnson CEO: 'We ended 2018 with great results' »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Feb

  • 25

    Feb

  • 25

    Feb

  • 06

    Mar

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

18:18
02/15/19
02/15
18:18
02/15/19
18:18
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

18:14
02/15/19
02/15
18:14
02/15/19
18:14
Hot Stocks
Biohaven treatment of multiple system atrophy granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$188.31

1.6 (0.86%)

18:11
02/15/19
02/15
18:11
02/15/19
18:11
Hot Stocks
Amgen treatment of Acute Myeloid Leukemia granted FDA orphan designation »

According to a post on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CE

Celanese

$100.19

1.19 (1.20%)

18:02
02/15/19
02/15
18:02
02/15/19
18:02
Hot Stocks
Celanese announces Acetyl Intermediates price increases in China »

Celanese will increase…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

, UNIT

Uniti Group

$20.00

0.53 (2.72%)

17:58
02/15/19
02/15
17:58
02/15/19
17:58
Periodicals
Court says Windstream defaulted on bonds in 2015, Bloomberg says »

A court has ruled that…

WIN

Windstream

$3.37

0.2 (6.31%)

UNIT

Uniti Group

$20.00

0.53 (2.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 28

    Feb

GLD

SPDR Gold Shares

$124.81

0.77 (0.62%)

17:41
02/15/19
02/15
17:41
02/15/19
17:41
Hot Stocks
SPDR Gold Shares holdings fall to 793.03MT from 796.85MT »

This is the lowest level…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.